Metabolic liver disease in the young adult

Mark E Mailliard, John L. Gollan

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

This chapter describes the gene mutations, phenotypes, diagnosis and therapy of the common metabolic liver diseases in young adulthood: haemochromatosis, Wilson disease, α1- anti-trypsin deficiency and cystic fibrosis. The remarkable variability of the phenotypical expression of the mutated genotypes makes screening recommendations and the establishment of prognosis for these liver disorders in young adults problematical. The diagnosis and therapy of the young adult with metabolic liver disease is discussed, with an emphasis on maintaining quality-of-life and balancing the importance of early intervention with the stigmatization of the diagnosis of potentially life-threatening liver disease. There is a critical need for the development of biochemical markers that would predict the risk of expression of clinical phenotypes and prognosis.

Original languageEnglish (US)
Pages (from-to)307-322
Number of pages16
JournalBailliere's Best Practice and Research in Clinical Gastroenterology
Volume17
Issue number2
DOIs
StatePublished - Apr 2003

Fingerprint

Metabolic Diseases
Liver Diseases
Young Adult
Phenotype
Stereotyping
Hepatolenticular Degeneration
Hemochromatosis
Cystic Fibrosis
Trypsin
Biomarkers
Genotype
Quality of Life
Mutation
Liver
Therapeutics
Genes

Keywords

  • Cystic fibrosis
  • Haemochromatosis
  • Liver disease
  • Wilson disease
  • α- anti-trypsin

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Metabolic liver disease in the young adult. / Mailliard, Mark E; Gollan, John L.

In: Bailliere's Best Practice and Research in Clinical Gastroenterology, Vol. 17, No. 2, 04.2003, p. 307-322.

Research output: Contribution to journalReview article

@article{467a2c0d17a84ad8b69cd36f6248113c,
title = "Metabolic liver disease in the young adult",
abstract = "This chapter describes the gene mutations, phenotypes, diagnosis and therapy of the common metabolic liver diseases in young adulthood: haemochromatosis, Wilson disease, α1- anti-trypsin deficiency and cystic fibrosis. The remarkable variability of the phenotypical expression of the mutated genotypes makes screening recommendations and the establishment of prognosis for these liver disorders in young adults problematical. The diagnosis and therapy of the young adult with metabolic liver disease is discussed, with an emphasis on maintaining quality-of-life and balancing the importance of early intervention with the stigmatization of the diagnosis of potentially life-threatening liver disease. There is a critical need for the development of biochemical markers that would predict the risk of expression of clinical phenotypes and prognosis.",
keywords = "Cystic fibrosis, Haemochromatosis, Liver disease, Wilson disease, α- anti-trypsin",
author = "Mailliard, {Mark E} and Gollan, {John L.}",
year = "2003",
month = "4",
doi = "10.1016/S1521-6918(02)00148-8",
language = "English (US)",
volume = "17",
pages = "307--322",
journal = "Bailliere's Best Practice and Research in Clinical Gastroenterology",
issn = "1521-6918",
publisher = "Bailliere Tindall Ltd",
number = "2",

}

TY - JOUR

T1 - Metabolic liver disease in the young adult

AU - Mailliard, Mark E

AU - Gollan, John L.

PY - 2003/4

Y1 - 2003/4

N2 - This chapter describes the gene mutations, phenotypes, diagnosis and therapy of the common metabolic liver diseases in young adulthood: haemochromatosis, Wilson disease, α1- anti-trypsin deficiency and cystic fibrosis. The remarkable variability of the phenotypical expression of the mutated genotypes makes screening recommendations and the establishment of prognosis for these liver disorders in young adults problematical. The diagnosis and therapy of the young adult with metabolic liver disease is discussed, with an emphasis on maintaining quality-of-life and balancing the importance of early intervention with the stigmatization of the diagnosis of potentially life-threatening liver disease. There is a critical need for the development of biochemical markers that would predict the risk of expression of clinical phenotypes and prognosis.

AB - This chapter describes the gene mutations, phenotypes, diagnosis and therapy of the common metabolic liver diseases in young adulthood: haemochromatosis, Wilson disease, α1- anti-trypsin deficiency and cystic fibrosis. The remarkable variability of the phenotypical expression of the mutated genotypes makes screening recommendations and the establishment of prognosis for these liver disorders in young adults problematical. The diagnosis and therapy of the young adult with metabolic liver disease is discussed, with an emphasis on maintaining quality-of-life and balancing the importance of early intervention with the stigmatization of the diagnosis of potentially life-threatening liver disease. There is a critical need for the development of biochemical markers that would predict the risk of expression of clinical phenotypes and prognosis.

KW - Cystic fibrosis

KW - Haemochromatosis

KW - Liver disease

KW - Wilson disease

KW - α- anti-trypsin

UR - http://www.scopus.com/inward/record.url?scp=0041408817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041408817&partnerID=8YFLogxK

U2 - 10.1016/S1521-6918(02)00148-8

DO - 10.1016/S1521-6918(02)00148-8

M3 - Review article

C2 - 12676121

AN - SCOPUS:0041408817

VL - 17

SP - 307

EP - 322

JO - Bailliere's Best Practice and Research in Clinical Gastroenterology

JF - Bailliere's Best Practice and Research in Clinical Gastroenterology

SN - 1521-6918

IS - 2

ER -